Agendia Apr 28, 2021 Agendia to Distribute Inivata Liquid Biopsy Breast Cancer Test in North America, Europe Dec 22, 2020 Agendia FLEX Registry Powers Genomics Research on Underrepresented Breast Cancer Patients Premium Nov 18, 2020 Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Aug 26, 2020 Agendia's MammaPrint Breast Cancer Risk Test Cost-Effective in Multi-Country Analysis Jun 12, 2020 New Data Support Role of Agendia BluePrint Test in Refining Breast Cancer Subtypes Premium May 21, 2019 Agendia, Imegen Ink Distribution Deal for Breast Cancer Tests in Spain, Portugal Oct 10, 2018 NCCN Update on Breast Cancer Genetic Testing Guidelines Marks Oncotype DX as 'Preferred' Test Feb 7, 2018 UK's NICE Finalizing Updated Breast Cancer Test Guidance Following Stakeholder Comments Premium Jul 10, 2017 ASCO Guideline Update Recommends Agendia MammaPrint in 1-3-Node Patients Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma
